Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

doi:10.1111/exd.13849

. 2019 Jan;28(1):94-103.

doi: 10.1111/exd.13849.

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

Eran Shavit¹, Afsaneh Alavi¹, Falk G Bechara², Richard G Bennett³, Marc Bourcier⁴, Ricardo Cibotti⁵, Steven Daveluy⁶, John W Frew⁷, Amit Garg⁸, Iltefat Hamzavi⁹, Lauren K Hoffman¹⁰, Jenny Hsaio¹¹, Joslyn Sciacca Kirby¹², Hadar Lev-Tov¹³, Erin Martinez¹⁴, Robert Micheletti¹⁵, Haley B Naik¹⁶, Aude Nassif¹⁷, Cynthia Nicholson¹⁸, Angie Parks-Miller^{2

19}, Zarine Patel^{10

20}, Vincent Piguet¹, Mayur Ramesh²¹, Barry Resnik¹³, Christopher Sayed²², Gregory Schultz²³, Aamir Siddiqui²⁴, Jerry Tan²⁵, Ximena Wortsman^{26

27}, Michelle A Lowes²⁸

Affiliations

¹ Department of Medicine, Division of Dermatology, Women College Hospital, University of Toronto, Toronto, Ontario, Canada.
² Department of Dermatology, Dermatologic Surgery Unit, Ruhr-University Bochum, Bochum, Germany.
³ Department of Dermatology, University of California, Los Angeles, Los Angeles, California.
⁴ Dermatology Clinic, Sherbrooke University, Moncton, New Brunswick, Canada.
⁵ National Institute of Arthritis and Musculoskeletal and skin diseases, National Institute of Health, Bethesda, Maryland.
⁶ Department of Dermatology, Wayne State University, Dearborn, Michigan.
⁷ Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.
⁸ Department of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, New York.
⁹ Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
¹⁰ Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
¹¹ Ronald Reagan UCLA Medical Center, Santa Monica, California.
¹² Department of Dermatology, Pennsylvania State, Hershey, Pennsylvania.
¹³ Department of Dermatology & Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida.
¹⁴ School of Social Work, Detroit, Michigan.
¹⁵ Departments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹⁶ Department of Dermatology, UCSF School of Medicine, San Francisco, California.
¹⁷ Institut Pasteur, Centre Medical, Paris, France.
¹⁸ Department of Dermatology, Wayne State University, Detroit, Michigan.
¹⁹ Clinical Research Manager, Henry Ford Hospital, Detroit, Michigan.
²⁰ Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York.
²¹ Department of Internal Medicine/Infectious Diseases, Henry Ford Hospital, Detroit, Michigan.
²² Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
²³ Institute of Wound Research, University of Florida, Gainesville, Florida.
²⁴ Department of Plastic Surgery, Henry Ford Hospital, Detroit, Michigan.
²⁵ Department of Medicine, University of Western Ontario, Windsor, Ontario, Canada.
²⁶ Department of Dermatology, Institute for Diagnostic Imaging and Research of the Skin and Soft Tissues, University of Chile, Santiago, Chile.
²⁷ Department of Dermatology, Pontifical Catholic University, Santiago, Chile.
²⁸ The Rockefeller University, New York City, New York.

PMID: 30484907
PMCID: PMC6600821
DOI: 10.1111/exd.13849

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

Eran Shavit et al. Exp Dermatol. 2019 Jan.

. 2019 Jan;28(1):94-103.

doi: 10.1111/exd.13849.

Authors

Affiliations

¹ Department of Medicine, Division of Dermatology, Women College Hospital, University of Toronto, Toronto, Ontario, Canada.
² Department of Dermatology, Dermatologic Surgery Unit, Ruhr-University Bochum, Bochum, Germany.
³ Department of Dermatology, University of California, Los Angeles, Los Angeles, California.
⁴ Dermatology Clinic, Sherbrooke University, Moncton, New Brunswick, Canada.
⁵ National Institute of Arthritis and Musculoskeletal and skin diseases, National Institute of Health, Bethesda, Maryland.
⁶ Department of Dermatology, Wayne State University, Dearborn, Michigan.
⁷ Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.
⁸ Department of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, New York.
⁹ Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
¹⁰ Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
¹¹ Ronald Reagan UCLA Medical Center, Santa Monica, California.
¹² Department of Dermatology, Pennsylvania State, Hershey, Pennsylvania.
¹³ Department of Dermatology & Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida.
¹⁴ School of Social Work, Detroit, Michigan.
¹⁵ Departments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹⁶ Department of Dermatology, UCSF School of Medicine, San Francisco, California.
¹⁷ Institut Pasteur, Centre Medical, Paris, France.
¹⁸ Department of Dermatology, Wayne State University, Detroit, Michigan.
¹⁹ Clinical Research Manager, Henry Ford Hospital, Detroit, Michigan.
²⁰ Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York.
²¹ Department of Internal Medicine/Infectious Diseases, Henry Ford Hospital, Detroit, Michigan.
²² Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
²³ Institute of Wound Research, University of Florida, Gainesville, Florida.
²⁴ Department of Plastic Surgery, Henry Ford Hospital, Detroit, Michigan.
²⁵ Department of Medicine, University of Western Ontario, Windsor, Ontario, Canada.
²⁶ Department of Dermatology, Institute for Diagnostic Imaging and Research of the Skin and Soft Tissues, University of Chile, Santiago, Chile.
²⁷ Department of Dermatology, Pontifical Catholic University, Santiago, Chile.
²⁸ The Rockefeller University, New York City, New York.

PMID: 30484907
PMCID: PMC6600821
DOI: 10.1111/exd.13849

Abstract

The 2nd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 03-05 November 2017 in Detroit, Michigan, USA. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF Inc.) founded in the USA, and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This was the second annual meeting of the SHSA with experts from different disciplines arriving from North America, Europe and Australia, in a joint aim to discuss most recent innovations, practical challenges and potential solutions to issues related in the management and care of Hidradenitis Suppurativa patients. The last session involved clinicians, patients and their families in an effort to educate them more about the disease.

Keywords: hidradenitis suppurativa; symposium.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

AA has received consulting fees from AbbVie, Actelion, Celgene, Galderma, GSK, InflaRx, Janssen, Kyowa Incyte Leo Pharma Novartis Pfizer Regeneron Roche Sanofi2 Genzyme UCB Valeant. FGB has received consulting fees from AbbVie. He is on the advisory Board for AbbVie, Janssen, and is an investigator for AbbVie, Janssen, Novartis and InflaRx. RGB has no conflicts of interest. MB is a Speaker for Astellas, AbbVie, Amgen, Eli-Lilly, La Roche-Posay, LEO Pharma, Janssen, Novartis, Pfizer, Merck, Valeant. He is on the Advisory Board for AbbVie, Amgen, Bausch Health, Eli-Lilly, La Roche-Posay, LEO Pharma, Janssen, Novartis, Pfizer, Merck, Valeant, and he is also an investigator of clinical trials for AbbVie, Amgen, Astellas, Basilea, Biogen, Celgene, Eli-Lilly, Galderma, Janssen, Johnson & Johnson, Janssen, Merck, Novartis, Ortho Biotech, Pfizer. RC has no conflicts of interest. SD is the speaker for AbbVie, and an investigator for Regeneron and InflaRx. JF has no conflicts of interest. AG has received consulting fees from AbbVie, Asana Biosciences, Janssen, Pfizer, UCB; grant support from AbbVie, UCB, National Psoriasis Foundation.IHH is the President of the HS Foundation, in a non-compensated role, an Investigator for; Lenicura (equipment received, no grant), AbbVie (grant paid to institution), Jansen (grant paid to institution), is or has been a consultant with fees received by UCB, Novartis, Incyte, Pfizer. LKH has no conflicts of interest. JH has no conflicts of interest. JSK is a speaker for AbbVie and has received consulting fees from Incyte and ChemoCentryx.HLT is the founder of Dermveda, Inc. and is an investigator for Factor Therapeutics, Molnlycke, BSN, TissuTech, Ilkos and Medline. EM has no conflicts of interest. RM has no conflicts of interest. MAL has received consulting fees from AbbVie, Xbiotech, Janssen, BSN: consultant/ Ad boards, and consultant on clinical trial for Incyte. HBN has received a research grant from Abbvie. AN has received travel grant from AbbVie, MSD. CN has no conflicts of interest. APM is a consultant for non-marketing materials for AbbVie and has received fees, serves or has served on an Advisory Board for AbbVie and has received fees, and serves or has served as a consultant for BSN and has received fees, is the President & Founding Director of Hope for HS in a non-compensated role and is an employee of the HS Foundation. ZP has no conflicts of interest. VP reports receiving educational grants from Abbvie, Celgene, Janssen, Naos, Lilly, Sanofi, Valeant, and non-financial support from La Roche-Posay. VP undertakes personal advisory work with Pfizer, AbbVie, Janssen, UCB, Novartis, Almirall and Celgene. MR has no conflicts of interest. BR has no conflicts of interest. CS is the speaker for Abbvie Inc. and for Norvartis, an investigator for UCB, and serves both as an investigator and consultant for InflaRx. GS in the last 12 months has been a consultant for Medline and has received research grants from Medline, B Braun, Next Science, Avadim, and Smith & Nephew. ES has no conflicts of interest. AS in the last 12 months has received research grants from Dabir Inc, PEMF Inc. and Smith & Nephew. JT was an advisor for Abbvie Inc. XW is the speaker for AbbVie, Janssen-Cilag and has received royalties from Springer.

Cited by

Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.
Posso-De Los Rios CJ, Sarfo A, Ghias M, Alhusayen R, Hamzavi I, Lowes MA, Alavi A. Posso-De Los Rios CJ, et al. Exp Dermatol. 2019 Jul;28(7):769-775. doi: 10.1111/exd.13928. Epub 2019 Apr 29. Exp Dermatol. 2019. PMID: 30924968 Free PMC article.
Surgical Management of Hidradenitis Suppurativa: Factors Associated with Postoperative Complications and Disease Recurrence.
Skorochod R, Margulis A, Adler N. Skorochod R, et al. Plast Reconstr Surg Glob Open. 2023 Jan 18;11(1):e4752. doi: 10.1097/GOX.0000000000004752. eCollection 2023 Jan. Plast Reconstr Surg Glob Open. 2023. PMID: 36776589 Free PMC article.

References

1. Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al., Exp. Dermatol. 2008, 17, 455. - PubMed
1. Beltrame A, Staffolani S, N. Engl. J. Med. 2017;377(25), 2474. - PubMed
1. van der Zee HH, Jemec GB, J. Am. Acad. Dermatol. 2015, 73(5 Suppl 1), S23. - PubMed
1. Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, et al., Br. J. Dermatol. 2015, 173(6), 1546. - PubMed
1. Garg A, Lavian J, Lin G, Strunk A, Alloo A, J. Am. Acad. Dermatol. 2017, 77(1), 118. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

R13 AR074881/AR/NIAMS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al., Exp. Dermatol. 2008, 17, 455. - PubMed

[2] Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al., Exp. Dermatol. 2008, 17, 455. - PubMed

[3] Beltrame A, Staffolani S, N. Engl. J. Med. 2017;377(25), 2474. - PubMed

[4] Beltrame A, Staffolani S, N. Engl. J. Med. 2017;377(25), 2474. - PubMed

[5] van der Zee HH, Jemec GB, J. Am. Acad. Dermatol. 2015, 73(5 Suppl 1), S23. - PubMed

[6] van der Zee HH, Jemec GB, J. Am. Acad. Dermatol. 2015, 73(5 Suppl 1), S23. - PubMed

[7] Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, et al., Br. J. Dermatol. 2015, 173(6), 1546. - PubMed

[8] Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, et al., Br. J. Dermatol. 2015, 173(6), 1546. - PubMed

[9] Garg A, Lavian J, Lin G, Strunk A, Alloo A, J. Am. Acad. Dermatol. 2017, 77(1), 118. - PubMed

[10] Garg A, Lavian J, Lin G, Strunk A, Alloo A, J. Am. Acad. Dermatol. 2017, 77(1), 118. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

Affiliations

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical